胚泡
套细胞淋巴瘤
生物
单变量分析
病理
单变量
淋巴瘤
多元分析
内科学
多元统计
医学
数学
统计
作者
Wen‐Yu Chuang,Wei-Hsiang Yu,Yen-Chen Lee,Qun-Yi Zhang,Hung Chang,Lee‐Yung Shih,Chi‐Ju Yeh,Samuel Mu-Tse Lin,Shang‐Hung Chang,Shir‐Hwa Ueng,Tong‐Hong Wang,Chuen Hsueh,Chang‐Fu Kuo,Shih‐Sung Chuang,Chao‐Yuan Yeh
标识
DOI:10.1016/j.ajpath.2022.08.006
摘要
Blastoid/pleomorphic morphology is associated with short survival in mantle cell lymphoma (MCL), but its prognostic value is overridden by Ki-67 in multivariate analysis. Herein, a nuclear segmentation model was developed using deep learning, and nuclei of tumor cells in 103 MCL cases were automatically delineated. Eight nuclear morphometric attributes were extracted from each nucleus. The mean, variance, skewness, and kurtosis of each attribute were calculated for each case, resulting in 32 morphometric parameters. Compared with those in classic MCL, 17 morphometric parameters were significantly different in blastoid/pleomorphic MCL. Using univariate analysis, 16 morphometric parameters (including 14 significantly different between classic and blastoid/pleomorphic MCL) emerged as significant prognostic factors. Using multivariate analysis, Biologic MCL International Prognostic Index (bMIPI) risk group (P = 0.025), low skewness of nuclear irregularity (P = 0.020), and high mean of nuclear irregularity (P = 0.047) emerged as independent adverse prognostic factors. Additionally, a morphometric score calculated from the skewness and mean of nuclear irregularity (P = 0.0038) was an independent prognostic factor in addition to bMIPI risk group (P = 0.025), and a summed morphometric bMIPI score was useful for risk stratification of patients with MCL (P = 0.000001). These results demonstrate, for the first time, that a nuclear morphometric score is an independent prognostic factor in MCL. It is more robust than blastoid/pleomorphic morphology and can be objectively measured.
科研通智能强力驱动
Strongly Powered by AbleSci AI